Opseu Pension Plan Trust Fund Biogen Inc. Transaction History

Opseu Pension Plan Trust Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $5,646 - $7,785	29 Added 0.34%	8,655 $2.26 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $20,066 - $23,863	-107 Reduced 1.23%	8,626 $1.75 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $50,961 - $64,208	263 Added 3.11%	8,733 $1.86 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $2,463 - $3,165	-11 Reduced 0.13%	8,470 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $89,990 - $117,357	-318 Reduced 3.61%	8,481 $2.39 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $849,520 - $1.36 Million	3,280 Added 59.43%	8,799 $3.07 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $33,770 - $39,563	139 Added 2.58%	5,519 $1.55 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $575,529 - $866,314	-2,436 Reduced 31.17%	5,380 $1.31 Million
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $185,603 - $214,302	701 Added 9.85%	7,816 $2.2 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $1.84 Million - $2.44 Million	7,115 New	7,115 $1.86 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.